🇺🇸 FDA
Pipeline program

trivalent seasonal influenza vaccine

PRO-INF-4013

Approved mab completed

Quick answer

trivalent seasonal influenza vaccine for Influenza is a Approved program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
SINOVAC BIOTECH LTD
Indication
Influenza
Phase
Approved
Modality
mab
Status
completed

Clinical trials